Artura Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
- Paid Up Capital ₹ 4.77 Cr
- Company Age 15 Year, 23 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 30.10 Cr
- Revenue Growth 37.16%
- Profit Growth 770.50%
- Ebitda 30.40%
- Net Worth 179.14%
- Total Assets 16.76%
About Artura Pharmaceuticals
Artura Pharmaceuticals Private Limited (APPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 10 February 2010 and has a history of 15 years. Its registered office is in Tiruvallur, Tamil Nadu, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 4.77 Cr.
The company currently has active open charges totaling ₹30.10 Cr.
Damodaram Harirajan, Vikram Harirajan, and Pushpakala Harirajan serve as directors at the Company.
Company Details
- Location
Tiruvallur, Tamil Nadu, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24233TN2010PTC074560
- Company No.
074560
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Feb 2010
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Pharma
Who are the key members and board of directors at Artura Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vikram Harirajan  | Managing Director | 10-Feb-2010 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Damodaram Harirajan | Director | 10-Feb-2010 | Current |
| Pushpakala Harirajan | Director | 10-Feb-2010 | Current |
Financial Performance of Artura Pharmaceuticals.
Artura Pharmaceuticals Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 37.16% increase. The company also saw a substantial improvement in profitability, with a 770.5% increase in profit. The company's net worth Soared by an impressive increase of 179.14%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Artura Pharmaceuticals?
In 2024, Artura Pharmaceuticals had a promoter holding of 48.37% and a public holding of 51.63%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Axon Drugs Private LimitedDamodaram Harirajan, Vikram Harirajan and 1 more are mutual person
Charges (Loans)
Open Charges
₹30.10 Cr
Satisfied Charges
₹0
Charges Breakdown by Lending Institutions
- Indian Overseas Bank : 30.10 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Sep 2021 | Indian Overseas Bank | ₹2.89 Cr | Open |
| 22 Jul 2013 | Indian Overseas Bank | ₹27.21 Cr | Open |
How Many Employees Work at Artura Pharmaceuticals?
Artura Pharmaceuticals has a workforce of 87 employees as of Feb 27, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Artura Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Artura Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Artura Pharmaceuticals
Recent activity within the organization
- Annual General Meeting
Artura Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
- Charges
A charge with Indian Overseas Bank of Rs. 27.21 Cr registered on 22 Jul 2013 with Charge ID 10439381 was modified on 31 Jul 2024.
- Balance Sheet
Artura Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai.
- Charges
A charge with Indian Overseas Bank amounted to Rs. 2.89 Cr with Charge ID 100489805 was registered on 24 Sep 2021.
- Charges
A charge with Indian Overseas Bank amounted to Rs. 27.21 Cr with Charge ID 10439381 was registered on 22 Jul 2013.
- Director Appointment
Damodaram Harirajan was appointed as a Director was appointed as a Director on 10 Feb 2010 & has been associated with this company since 15 years 23 days .
Recent News, Updates & Announcement
Frequently asked questions
What is the Incorporation or founding date of Artura Pharmaceuticals Private Limited?
Artura Pharmaceuticals Private Limited was incorporated on 10 Feb 2010.
What is authorized share capital and paid-up capital of Artura Pharmaceuticals Private Limited?
The authorized share capital of Artura Pharmaceuticals Private Limited is ₹ 5.00 Cr and paid-up capital is ₹ 4.77 Cr.
Who are the current board members & directors of Artura Pharmaceuticals Private Limited?
Currently 3 directors are associated with Artura Pharmaceuticals Private Limited.
- Damodaram Harirajan
- Vikram Harirajan
- Pushpakala Harirajan
What is the registered address of Artura Pharmaceuticals Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Artura Pharmaceuticals Private Limited is Plot No.14 Santhosh Nagar, Korattur North India, Chennai, Tamil Nadu, 600076.
What is the corporate identification number (CIN) and company number of Artura Pharmaceuticals Private Limited?
The corporate identification number (CIN) of Artura Pharmaceuticals Private Limited is U24233TN2010PTC074560 and the company number is 074560 as per Ministry of Corporate Affairs (MCA).
What is the official website of Artura Pharmaceuticals Private Limited?
The Official website of Artura Pharmaceuticals Private Limited is https://www.arturapharma.com
What has been the recent revenue trend for Artura Pharmaceuticals Private Limited?
According to the financial reports for the fiscal year 2024, the revenue trend for Artura Pharmaceuticals Private Limited has risen by 37.16%.
How many employees does Artura Pharmaceuticals Private Limited currently have?
As Per 2024 financial reports, 87 employees are currently employed by Artura Pharmaceuticals Private Limited.
What change has been observed in the net worth of Artura Pharmaceuticals Private Limited, and by what percentage?
The financial reports for the fiscal year 2024 indicates that The net worth of Artura Pharmaceuticals Private Limited has experienced an upsurge of 179.14%.
What are the total open charges for Artura Pharmaceuticals Private Limited?
As per the financial statements for fiscal Year 2024, The total open charges for Artura Pharmaceuticals Private Limited amount to ₹ 30.10 Cr.
When was the last Balance Sheet of Artura Pharmaceuticals Private Limited filed with the ROC?
The most recent Balance Sheet for Artura Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2024.